Original Research
Published on 03 Mar 2026
Preclinical activity of SHR-A1921, a novel antibody-drug conjugate targeting trophoblast cell-surface antigen2 (Trop-2) in prostate cancer
in Pharmacology of Anti-Cancer Drugs
- 426 views
Original Research
Published on 03 Mar 2026
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 03 Mar 2026
in Urban Science
Review
Published on 03 Mar 2026
in Medicinal and Pharmaceutical Chemistry
Original Research
Published on 03 Mar 2026
in Health Psychology
Original Research
Published on 03 Mar 2026
in Food Microbiology
Review
Published on 03 Mar 2026
in Networks and Communications
Original Research
Published on 03 Mar 2026
in Psychology in Education
Original Research
Published on 03 Mar 2026
in Geriatric Medicine
Correction
Published on 03 Mar 2026
in Environmental Informatics and Remote Sensing
Review
Published on 03 Mar 2026
in Computational Genomics
Original Research
Published on 03 Mar 2026
in Precision Medicine
Case Report
Published on 03 Mar 2026
in Cancer Molecular Targets and Therapeutics
Systematic Review
Published on 03 Mar 2026
in Clinical Diabetes
Review
Published on 03 Mar 2026
in Cancer Immunity and Immunotherapy
Systematic Review
Published on 03 Mar 2026
in Immunological Tolerance and Regulation
Original Research
Published on 03 Mar 2026
in Neurorehabilitation